These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

922 related articles for article (PubMed ID: 33711385)

  • 1. Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases.
    Anthony DP; Hegde M; Shetty SS; Rafic T; Mutalik S; Rao BSS
    Life Sci; 2021 Jun; 274():119326. PubMed ID: 33711385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Getting into the brain: approaches to enhance brain drug delivery.
    Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
    CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
    Tashima T
    Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-enabled delivery systems across the blood-brain barrier.
    Hwang SR; Kim K
    Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential receptor-mediated drug targeting to the diseased brain.
    Rip J; Schenk GJ; de Boer AG
    Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier.
    Lajoie JM; Shusta EV
    Annu Rev Pharmacol Toxicol; 2015; 55():613-31. PubMed ID: 25340933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.
    Hersh DS; Wadajkar AS; Roberts N; Perez JG; Connolly NP; Frenkel V; Winkles JA; Woodworth GF; Kim AJ
    Curr Pharm Des; 2016; 22(9):1177-1193. PubMed ID: 26685681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric nanoparticles for the drug delivery to the central nervous system.
    Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
    Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
    Zhao X; Ye Y; Ge S; Sun P; Yu P
    Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembled amphiphilic core-shell nanocarriers in line with the modern strategies for brain delivery.
    Elezaby RS; Gad HA; Metwally AA; Geneidi AS; Awad GA
    J Control Release; 2017 Sep; 261():43-61. PubMed ID: 28648865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles as novel carrier for brain delivery: a review.
    Agarwal A; Lariya N; Saraogi G; Dubey N; Agrawal H; Agrawal GP
    Curr Pharm Des; 2009; 15(8):917-25. PubMed ID: 19275654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-Appended BBB-Targeted Nanocarriers (LABTNs).
    Jain A; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2015; 32(2):149-80. PubMed ID: 25955883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.
    Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I
    Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of nano-therapeutics for major disorders of the central nervous system.
    Gao H; Pang Z; Jiang X
    Pharm Res; 2013 Oct; 30(10):2485-98. PubMed ID: 23797465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current advances in delivery of biotherapeutics across the blood-brain barrier.
    Rajadhyaksha M; Boyden T; Liras J; El-Kattan A; Brodfuehrer J
    Curr Drug Discov Technol; 2011 Jun; 8(2):87-101. PubMed ID: 21513485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting the properties of biomolecules for brain targeting of nanoparticulate systems.
    Cramer S; Rempe R; Galla HJ
    Curr Med Chem; 2012; 19(19):3163-87. PubMed ID: 22612701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tight junction modulation at the blood-brain barrier: Current and future perspectives.
    Hashimoto Y; Campbell M
    Biochim Biophys Acta Biomembr; 2020 Sep; 1862(9):183298. PubMed ID: 32353377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier structure and function and the challenges for CNS drug delivery.
    Abbott NJ
    J Inherit Metab Dis; 2013 May; 36(3):437-49. PubMed ID: 23609350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.